nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Lomustine—hematologic cancer	0.0427	0.0738	CbGbCtD
Oxymorphone—CYP2D6—Idarubicin—hematologic cancer	0.0381	0.0658	CbGbCtD
Oxymorphone—CYP2D6—Hydroxyurea—hematologic cancer	0.0324	0.0559	CbGbCtD
Oxymorphone—CYP3A4—Bexarotene—hematologic cancer	0.0292	0.0505	CbGbCtD
Oxymorphone—CYP2D6—Bortezomib—hematologic cancer	0.0282	0.0487	CbGbCtD
Oxymorphone—CYP3A4—Busulfan—hematologic cancer	0.0272	0.0469	CbGbCtD
Oxymorphone—CYP3A4—Lomustine—hematologic cancer	0.0272	0.0469	CbGbCtD
Oxymorphone—CYP3A4—Thiotepa—hematologic cancer	0.0242	0.0418	CbGbCtD
Oxymorphone—CYP2D6—Imatinib—hematologic cancer	0.0206	0.0356	CbGbCtD
Oxymorphone—CYP3A4—Methoxsalen—hematologic cancer	0.0188	0.0325	CbGbCtD
Oxymorphone—CYP2D6—Nilotinib—hematologic cancer	0.0188	0.0324	CbGbCtD
Oxymorphone—CYP2D6—Vinorelbine—hematologic cancer	0.0186	0.0321	CbGbCtD
Oxymorphone—CYP3A4—Bortezomib—hematologic cancer	0.0179	0.0309	CbGbCtD
Oxymorphone—CYP3A4—Daunorubicin—hematologic cancer	0.0171	0.0296	CbGbCtD
Oxymorphone—CYP3A4—Cytarabine—hematologic cancer	0.0151	0.0261	CbGbCtD
Oxymorphone—CYP3A4—Teniposide—hematologic cancer	0.0149	0.0257	CbGbCtD
Oxymorphone—CYP3A4—Ifosfamide—hematologic cancer	0.0137	0.0237	CbGbCtD
Oxymorphone—CYP3A4—Imatinib—hematologic cancer	0.0131	0.0227	CbGbCtD
Oxymorphone—CYP3A4—Ruxolitinib—hematologic cancer	0.0124	0.0213	CbGbCtD
Oxymorphone—CYP3A4—Nilotinib—hematologic cancer	0.0119	0.0206	CbGbCtD
Oxymorphone—CYP3A4—Vinorelbine—hematologic cancer	0.0118	0.0204	CbGbCtD
Oxymorphone—CYP2D6—Vinblastine—hematologic cancer	0.0115	0.0198	CbGbCtD
Oxymorphone—CYP3A4—Triamcinolone—hematologic cancer	0.0108	0.0187	CbGbCtD
Oxymorphone—CYP3A4—Dasatinib—hematologic cancer	0.0105	0.0182	CbGbCtD
Oxymorphone—CYP3A4—Mitoxantrone—hematologic cancer	0.0104	0.018	CbGbCtD
Oxymorphone—CYP3A4—Betamethasone—hematologic cancer	0.00928	0.016	CbGbCtD
Oxymorphone—CYP3A4—Prednisolone—hematologic cancer	0.00916	0.0158	CbGbCtD
Oxymorphone—CYP3A4—Prednisone—hematologic cancer	0.00865	0.0149	CbGbCtD
Oxymorphone—CYP2D6—Dexamethasone—hematologic cancer	0.00849	0.0147	CbGbCtD
Oxymorphone—CYP3A4—Irinotecan—hematologic cancer	0.0082	0.0142	CbGbCtD
Oxymorphone—CYP3A4—Vinblastine—hematologic cancer	0.00729	0.0126	CbGbCtD
Oxymorphone—CYP3A4—Vincristine—hematologic cancer	0.00717	0.0124	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—hematologic cancer	0.00704	0.0122	CbGbCtD
Oxymorphone—CYP3A4—Etoposide—hematologic cancer	0.00657	0.0113	CbGbCtD
Oxymorphone—CYP3A4—Dexamethasone—hematologic cancer	0.0054	0.00932	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—hematologic cancer	0.00448	0.00773	CbGbCtD
Oxymorphone—Naloxone—CREB1—hematologic cancer	0.00208	0.383	CrCbGaD
Oxymorphone—Naltrexone—UGT1A1—hematologic cancer	0.00101	0.185	CrCbGaD
Oxymorphone—Morphine—UGT1A1—hematologic cancer	0.000619	0.114	CrCbGaD
Oxymorphone—Buprenorphine—ABCG2—hematologic cancer	0.000415	0.0765	CrCbGaD
Oxymorphone—Naloxone—ESR1—hematologic cancer	0.000404	0.0744	CrCbGaD
Oxymorphone—Naltrexone—ABCB1—hematologic cancer	0.000235	0.0434	CrCbGaD
Oxymorphone—Naloxone—ALB—hematologic cancer	0.00018	0.0331	CrCbGaD
Oxymorphone—Buprenorphine—ABCB1—hematologic cancer	0.000173	0.0319	CrCbGaD
Oxymorphone—Naloxone—ABCB1—hematologic cancer	0.000172	0.0316	CrCbGaD
Oxymorphone—Morphine—ABCB1—hematologic cancer	0.000145	0.0267	CrCbGaD
Oxymorphone—Diarrhoea—Cisplatin—hematologic cancer	6.05e-05	0.000177	CcSEcCtD
Oxymorphone—Anxiety—Prednisone—hematologic cancer	6.04e-05	0.000177	CcSEcCtD
Oxymorphone—Vomiting—Gemcitabine—hematologic cancer	6.04e-05	0.000176	CcSEcCtD
Oxymorphone—Insomnia—Dexamethasone—hematologic cancer	6.03e-05	0.000176	CcSEcCtD
Oxymorphone—Insomnia—Betamethasone—hematologic cancer	6.03e-05	0.000176	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—hematologic cancer	6.02e-05	0.000176	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.02e-05	0.000176	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—hematologic cancer	5.99e-05	0.000175	CcSEcCtD
Oxymorphone—Dermatitis—Gemcitabine—hematologic cancer	5.98e-05	0.000175	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—hematologic cancer	5.98e-05	0.000175	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—hematologic cancer	5.97e-05	0.000175	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—hematologic cancer	5.95e-05	0.000174	CcSEcCtD
Oxymorphone—Headache—Gemcitabine—hematologic cancer	5.95e-05	0.000174	CcSEcCtD
Oxymorphone—Nausea—Vincristine—hematologic cancer	5.94e-05	0.000174	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—hematologic cancer	5.94e-05	0.000174	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—hematologic cancer	5.94e-05	0.000174	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisolone—hematologic cancer	5.89e-05	0.000172	CcSEcCtD
Oxymorphone—Dyspepsia—Betamethasone—hematologic cancer	5.87e-05	0.000172	CcSEcCtD
Oxymorphone—Dyspepsia—Dexamethasone—hematologic cancer	5.87e-05	0.000172	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—hematologic cancer	5.84e-05	0.000171	CcSEcCtD
Oxymorphone—Urticaria—Triamcinolone—hematologic cancer	5.84e-05	0.000171	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—hematologic cancer	5.82e-05	0.00017	CcSEcCtD
Oxymorphone—Body temperature increased—Triamcinolone—hematologic cancer	5.81e-05	0.00017	CcSEcCtD
Oxymorphone—Oedema—Prednisone—hematologic cancer	5.81e-05	0.00017	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—hematologic cancer	5.8e-05	0.00017	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—hematologic cancer	5.8e-05	0.00017	CcSEcCtD
Oxymorphone—Decreased appetite—Dexamethasone—hematologic cancer	5.8e-05	0.00017	CcSEcCtD
Oxymorphone—Decreased appetite—Betamethasone—hematologic cancer	5.8e-05	0.00017	CcSEcCtD
Oxymorphone—Nausea—Mitoxantrone—hematologic cancer	5.79e-05	0.000169	CcSEcCtD
Oxymorphone—Nausea—Irinotecan—hematologic cancer	5.79e-05	0.000169	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—hematologic cancer	5.78e-05	0.000169	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—hematologic cancer	5.76e-05	0.000169	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.76e-05	0.000168	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.76e-05	0.000168	CcSEcCtD
Oxymorphone—Fatigue—Betamethasone—hematologic cancer	5.75e-05	0.000168	CcSEcCtD
Oxymorphone—Fatigue—Dexamethasone—hematologic cancer	5.75e-05	0.000168	CcSEcCtD
Oxymorphone—Pruritus—Etoposide—hematologic cancer	5.73e-05	0.000168	CcSEcCtD
Oxymorphone—Shock—Prednisone—hematologic cancer	5.72e-05	0.000167	CcSEcCtD
Oxymorphone—Pain—Betamethasone—hematologic cancer	5.7e-05	0.000167	CcSEcCtD
Oxymorphone—Pain—Dexamethasone—hematologic cancer	5.7e-05	0.000167	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—hematologic cancer	5.7e-05	0.000167	CcSEcCtD
Oxymorphone—Nervous system disorder—Prednisone—hematologic cancer	5.7e-05	0.000167	CcSEcCtD
Oxymorphone—Tachycardia—Prednisone—hematologic cancer	5.67e-05	0.000166	CcSEcCtD
Oxymorphone—Skin disorder—Prednisone—hematologic cancer	5.64e-05	0.000165	CcSEcCtD
Oxymorphone—Nausea—Gemcitabine—hematologic cancer	5.64e-05	0.000165	CcSEcCtD
Oxymorphone—Vomiting—Cisplatin—hematologic cancer	5.63e-05	0.000165	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisone—hematologic cancer	5.62e-05	0.000164	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—hematologic cancer	5.61e-05	0.000164	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—hematologic cancer	5.6e-05	0.000164	CcSEcCtD
Oxymorphone—Dermatitis—Cisplatin—hematologic cancer	5.57e-05	0.000163	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—hematologic cancer	5.57e-05	0.000163	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—hematologic cancer	5.55e-05	0.000162	CcSEcCtD
Oxymorphone—Anorexia—Prednisone—hematologic cancer	5.54e-05	0.000162	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—hematologic cancer	5.53e-05	0.000162	CcSEcCtD
Oxymorphone—Feeling abnormal—Betamethasone—hematologic cancer	5.5e-05	0.000161	CcSEcCtD
Oxymorphone—Feeling abnormal—Dexamethasone—hematologic cancer	5.5e-05	0.000161	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—hematologic cancer	5.49e-05	0.000161	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—hematologic cancer	5.49e-05	0.000161	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—hematologic cancer	5.49e-05	0.00016	CcSEcCtD
Oxymorphone—Tension—Epirubicin—hematologic cancer	5.46e-05	0.00016	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.45e-05	0.00016	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Betamethasone—hematologic cancer	5.45e-05	0.00016	CcSEcCtD
Oxymorphone—Hypersensitivity—Triamcinolone—hematologic cancer	5.42e-05	0.000158	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—hematologic cancer	5.41e-05	0.000158	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—hematologic cancer	5.37e-05	0.000157	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—hematologic cancer	5.36e-05	0.000157	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—hematologic cancer	5.34e-05	0.000156	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—hematologic cancer	5.34e-05	0.000156	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—hematologic cancer	5.33e-05	0.000156	CcSEcCtD
Oxymorphone—Urticaria—Dexamethasone—hematologic cancer	5.3e-05	0.000155	CcSEcCtD
Oxymorphone—Urticaria—Betamethasone—hematologic cancer	5.3e-05	0.000155	CcSEcCtD
Oxymorphone—Dizziness—Prednisolone—hematologic cancer	5.29e-05	0.000155	CcSEcCtD
Oxymorphone—Asthenia—Triamcinolone—hematologic cancer	5.27e-05	0.000154	CcSEcCtD
Oxymorphone—Abdominal pain—Betamethasone—hematologic cancer	5.27e-05	0.000154	CcSEcCtD
Oxymorphone—Body temperature increased—Dexamethasone—hematologic cancer	5.27e-05	0.000154	CcSEcCtD
Oxymorphone—Body temperature increased—Betamethasone—hematologic cancer	5.27e-05	0.000154	CcSEcCtD
Oxymorphone—Abdominal pain—Dexamethasone—hematologic cancer	5.27e-05	0.000154	CcSEcCtD
Oxymorphone—Nausea—Cisplatin—hematologic cancer	5.26e-05	0.000154	CcSEcCtD
Oxymorphone—Insomnia—Prednisone—hematologic cancer	5.25e-05	0.000154	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—hematologic cancer	5.25e-05	0.000153	CcSEcCtD
Oxymorphone—Pruritus—Triamcinolone—hematologic cancer	5.2e-05	0.000152	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—hematologic cancer	5.18e-05	0.000152	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—hematologic cancer	5.15e-05	0.000151	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—hematologic cancer	5.15e-05	0.000151	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—hematologic cancer	5.15e-05	0.000151	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—hematologic cancer	5.12e-05	0.00015	CcSEcCtD
Oxymorphone—Dyspepsia—Prednisone—hematologic cancer	5.11e-05	0.00015	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—hematologic cancer	5.11e-05	0.000149	CcSEcCtD
Oxymorphone—Headache—Etoposide—hematologic cancer	5.08e-05	0.000148	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—hematologic cancer	5.08e-05	0.000148	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—hematologic cancer	5.06e-05	0.000148	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—hematologic cancer	5.05e-05	0.000148	CcSEcCtD
Oxymorphone—Decreased appetite—Prednisone—hematologic cancer	5.05e-05	0.000148	CcSEcCtD
Oxymorphone—Dermatitis—Prednisolone—hematologic cancer	5.04e-05	0.000147	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.03e-05	0.000147	CcSEcCtD
Oxymorphone—Fatigue—Prednisone—hematologic cancer	5.01e-05	0.000146	CcSEcCtD
Oxymorphone—Headache—Prednisolone—hematologic cancer	5.01e-05	0.000146	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—hematologic cancer	5e-05	0.000146	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—hematologic cancer	5e-05	0.000146	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—hematologic cancer	4.99e-05	0.000146	CcSEcCtD
Oxymorphone—Constipation—Prednisone—hematologic cancer	4.97e-05	0.000145	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—hematologic cancer	4.92e-05	0.000144	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—hematologic cancer	4.9e-05	0.000143	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—hematologic cancer	4.89e-05	0.000143	CcSEcCtD
Oxymorphone—Dizziness—Triamcinolone—hematologic cancer	4.86e-05	0.000142	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—hematologic cancer	4.85e-05	0.000142	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—hematologic cancer	4.82e-05	0.000141	CcSEcCtD
Oxymorphone—Nausea—Etoposide—hematologic cancer	4.81e-05	0.000141	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—hematologic cancer	4.81e-05	0.000141	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisone—hematologic cancer	4.79e-05	0.00014	CcSEcCtD
Oxymorphone—Asthenia—Dexamethasone—hematologic cancer	4.79e-05	0.00014	CcSEcCtD
Oxymorphone—Asthenia—Betamethasone—hematologic cancer	4.79e-05	0.00014	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—hematologic cancer	4.76e-05	0.000139	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Prednisone—hematologic cancer	4.75e-05	0.000139	CcSEcCtD
Oxymorphone—Nausea—Prednisolone—hematologic cancer	4.75e-05	0.000139	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—hematologic cancer	4.74e-05	0.000139	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—hematologic cancer	4.73e-05	0.000138	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—hematologic cancer	4.72e-05	0.000138	CcSEcCtD
Oxymorphone—Pruritus—Betamethasone—hematologic cancer	4.72e-05	0.000138	CcSEcCtD
Oxymorphone—Pruritus—Dexamethasone—hematologic cancer	4.72e-05	0.000138	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—hematologic cancer	4.72e-05	0.000138	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.71e-05	0.000138	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—hematologic cancer	4.69e-05	0.000137	CcSEcCtD
Oxymorphone—Vomiting—Triamcinolone—hematologic cancer	4.67e-05	0.000137	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—hematologic cancer	4.64e-05	0.000136	CcSEcCtD
Oxymorphone—Dermatitis—Triamcinolone—hematologic cancer	4.63e-05	0.000135	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—hematologic cancer	4.63e-05	0.000135	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—hematologic cancer	4.63e-05	0.000135	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—hematologic cancer	4.62e-05	0.000135	CcSEcCtD
Oxymorphone—Urticaria—Prednisone—hematologic cancer	4.62e-05	0.000135	CcSEcCtD
Oxymorphone—Headache—Triamcinolone—hematologic cancer	4.61e-05	0.000135	CcSEcCtD
Oxymorphone—Abdominal pain—Prednisone—hematologic cancer	4.59e-05	0.000134	CcSEcCtD
Oxymorphone—Body temperature increased—Prednisone—hematologic cancer	4.59e-05	0.000134	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—hematologic cancer	4.58e-05	0.000134	CcSEcCtD
Oxymorphone—Diarrhoea—Betamethasone—hematologic cancer	4.56e-05	0.000133	CcSEcCtD
Oxymorphone—Diarrhoea—Dexamethasone—hematologic cancer	4.56e-05	0.000133	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—hematologic cancer	4.55e-05	0.000133	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—hematologic cancer	4.54e-05	0.000133	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—hematologic cancer	4.54e-05	0.000133	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—hematologic cancer	4.53e-05	0.000132	CcSEcCtD
Oxymorphone—Shock—Epirubicin—hematologic cancer	4.47e-05	0.000131	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—hematologic cancer	4.46e-05	0.000131	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—hematologic cancer	4.46e-05	0.00013	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—hematologic cancer	4.45e-05	0.00013	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—hematologic cancer	4.43e-05	0.00013	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—hematologic cancer	4.41e-05	0.000129	CcSEcCtD
Oxymorphone—Dizziness—Betamethasone—hematologic cancer	4.41e-05	0.000129	CcSEcCtD
Oxymorphone—Dizziness—Dexamethasone—hematologic cancer	4.41e-05	0.000129	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—hematologic cancer	4.39e-05	0.000128	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—hematologic cancer	4.39e-05	0.000128	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—hematologic cancer	4.39e-05	0.000128	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—hematologic cancer	4.37e-05	0.000128	CcSEcCtD
Oxymorphone—Nausea—Triamcinolone—hematologic cancer	4.37e-05	0.000128	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.36e-05	0.000127	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—hematologic cancer	4.33e-05	0.000127	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—hematologic cancer	4.33e-05	0.000127	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—hematologic cancer	4.32e-05	0.000126	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—hematologic cancer	4.29e-05	0.000125	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisone—hematologic cancer	4.28e-05	0.000125	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—hematologic cancer	4.27e-05	0.000125	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—hematologic cancer	4.25e-05	0.000124	CcSEcCtD
Oxymorphone—Vomiting—Dexamethasone—hematologic cancer	4.24e-05	0.000124	CcSEcCtD
Oxymorphone—Vomiting—Betamethasone—hematologic cancer	4.24e-05	0.000124	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—hematologic cancer	4.24e-05	0.000124	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—hematologic cancer	4.22e-05	0.000123	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—hematologic cancer	4.2e-05	0.000123	CcSEcCtD
Oxymorphone—Dermatitis—Betamethasone—hematologic cancer	4.2e-05	0.000123	CcSEcCtD
Oxymorphone—Dermatitis—Dexamethasone—hematologic cancer	4.2e-05	0.000123	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.19e-05	0.000123	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—hematologic cancer	4.19e-05	0.000122	CcSEcCtD
Oxymorphone—Headache—Betamethasone—hematologic cancer	4.18e-05	0.000122	CcSEcCtD
Oxymorphone—Headache—Dexamethasone—hematologic cancer	4.18e-05	0.000122	CcSEcCtD
Oxymorphone—Asthenia—Prednisone—hematologic cancer	4.17e-05	0.000122	CcSEcCtD
Oxymorphone—Pain—Methotrexate—hematologic cancer	4.15e-05	0.000121	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—hematologic cancer	4.14e-05	0.000121	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—hematologic cancer	4.12e-05	0.000121	CcSEcCtD
Oxymorphone—Pruritus—Prednisone—hematologic cancer	4.11e-05	0.00012	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—hematologic cancer	4.11e-05	0.00012	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—hematologic cancer	4.1e-05	0.00012	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—hematologic cancer	4.08e-05	0.000119	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—hematologic cancer	4.06e-05	0.000119	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—hematologic cancer	4.05e-05	0.000118	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—hematologic cancer	4.04e-05	0.000118	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—hematologic cancer	4.01e-05	0.000117	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—hematologic cancer	4e-05	0.000117	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—hematologic cancer	4e-05	0.000117	CcSEcCtD
Oxymorphone—Diarrhoea—Prednisone—hematologic cancer	3.97e-05	0.000116	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—hematologic cancer	3.97e-05	0.000116	CcSEcCtD
Oxymorphone—Nausea—Betamethasone—hematologic cancer	3.96e-05	0.000116	CcSEcCtD
Oxymorphone—Nausea—Dexamethasone—hematologic cancer	3.96e-05	0.000116	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—hematologic cancer	3.95e-05	0.000115	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—hematologic cancer	3.93e-05	0.000115	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.92e-05	0.000115	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—hematologic cancer	3.92e-05	0.000115	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—hematologic cancer	3.89e-05	0.000114	CcSEcCtD
Oxymorphone—Pain—Epirubicin—hematologic cancer	3.89e-05	0.000114	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—hematologic cancer	3.86e-05	0.000113	CcSEcCtD
Oxymorphone—Dizziness—Prednisone—hematologic cancer	3.84e-05	0.000112	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—hematologic cancer	3.84e-05	0.000112	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—hematologic cancer	3.84e-05	0.000112	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—hematologic cancer	3.8e-05	0.000111	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—hematologic cancer	3.75e-05	0.00011	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—hematologic cancer	3.74e-05	0.000109	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—hematologic cancer	3.74e-05	0.000109	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—hematologic cancer	3.72e-05	0.000109	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—hematologic cancer	3.7e-05	0.000108	CcSEcCtD
Oxymorphone—Vomiting—Prednisone—hematologic cancer	3.69e-05	0.000108	CcSEcCtD
Oxymorphone—Dermatitis—Prednisone—hematologic cancer	3.66e-05	0.000107	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—hematologic cancer	3.65e-05	0.000107	CcSEcCtD
Oxymorphone—Headache—Prednisone—hematologic cancer	3.64e-05	0.000106	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.63e-05	0.000106	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—hematologic cancer	3.62e-05	0.000106	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—hematologic cancer	3.61e-05	0.000106	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—hematologic cancer	3.6e-05	0.000105	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—hematologic cancer	3.6e-05	0.000105	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—hematologic cancer	3.59e-05	0.000105	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—hematologic cancer	3.59e-05	0.000105	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—hematologic cancer	3.58e-05	0.000105	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—hematologic cancer	3.48e-05	0.000102	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—hematologic cancer	3.46e-05	0.000101	CcSEcCtD
Oxymorphone—Nausea—Prednisone—hematologic cancer	3.45e-05	0.000101	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.44e-05	0.000101	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—hematologic cancer	3.43e-05	0.0001	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—hematologic cancer	3.35e-05	9.79e-05	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—hematologic cancer	3.34e-05	9.77e-05	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—hematologic cancer	3.32e-05	9.72e-05	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—hematologic cancer	3.32e-05	9.72e-05	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—hematologic cancer	3.32e-05	9.71e-05	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—hematologic cancer	3.26e-05	9.53e-05	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—hematologic cancer	3.21e-05	9.4e-05	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—hematologic cancer	3.21e-05	9.39e-05	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—hematologic cancer	3.11e-05	9.09e-05	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—hematologic cancer	3.1e-05	9.06e-05	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—hematologic cancer	3.09e-05	9.03e-05	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—hematologic cancer	3.06e-05	8.94e-05	CcSEcCtD
Oxymorphone—Headache—Methotrexate—hematologic cancer	3.04e-05	8.89e-05	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—hematologic cancer	3.02e-05	8.82e-05	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—hematologic cancer	3e-05	8.79e-05	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—hematologic cancer	2.97e-05	8.7e-05	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—hematologic cancer	2.89e-05	8.45e-05	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—hematologic cancer	2.88e-05	8.43e-05	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—hematologic cancer	2.88e-05	8.41e-05	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—hematologic cancer	2.86e-05	8.37e-05	CcSEcCtD
Oxymorphone—Headache—Epirubicin—hematologic cancer	2.85e-05	8.32e-05	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—hematologic cancer	2.78e-05	8.13e-05	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—hematologic cancer	2.7e-05	7.89e-05	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—hematologic cancer	2.67e-05	7.82e-05	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—hematologic cancer	2.65e-05	7.74e-05	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—hematologic cancer	2.63e-05	7.7e-05	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—hematologic cancer	2.5e-05	7.3e-05	CcSEcCtD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	1.25e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KIT—hematologic cancer	1.25e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	1.25e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	1.25e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TSC2—hematologic cancer	1.24e-05	0.000169	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTAP—hematologic cancer	1.24e-05	0.000169	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGF1—hematologic cancer	1.24e-05	0.000168	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CSF2—hematologic cancer	1.24e-05	0.000168	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	1.23e-05	0.000167	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.22e-05	0.000167	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.22e-05	0.000167	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	1.22e-05	0.000166	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	1.22e-05	0.000166	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	1.22e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	1.2e-05	0.000164	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	1.2e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	1.2e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	1.2e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JAK1—hematologic cancer	1.19e-05	0.000162	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	1.19e-05	0.000162	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.19e-05	0.000162	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CREB1—hematologic cancer	1.19e-05	0.000162	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	1.19e-05	0.000161	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—BRAF—hematologic cancer	1.18e-05	0.00016	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL2—hematologic cancer	1.17e-05	0.000159	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6R—hematologic cancer	1.16e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ESR1—hematologic cancer	1.16e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	1.16e-05	0.000158	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NUP98—hematologic cancer	1.16e-05	0.000157	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FN1—hematologic cancer	1.15e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—BAD—hematologic cancer	1.13e-05	0.000154	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	1.13e-05	0.000154	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	1.12e-05	0.000153	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.12e-05	0.000153	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.12e-05	0.000153	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	1.11e-05	0.000152	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NUP214—hematologic cancer	1.11e-05	0.000152	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	1.11e-05	0.000151	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—FHL2—hematologic cancer	1.11e-05	0.000151	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2—hematologic cancer	1.11e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TERT—hematologic cancer	1.1e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	1.1e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CD80—hematologic cancer	1.1e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	1.1e-05	0.000149	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KIT—hematologic cancer	1.1e-05	0.000149	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	1.1e-05	0.000149	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTR—hematologic cancer	1.09e-05	0.000148	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.09e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.09e-05	0.000148	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AGRN—hematologic cancer	1.09e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	1.08e-05	0.000147	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	1.08e-05	0.000147	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	1.08e-05	0.000146	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ENO2—hematologic cancer	1.07e-05	0.000146	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FGF2—hematologic cancer	1.05e-05	0.000143	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	1.05e-05	0.000143	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TSC2—hematologic cancer	1.05e-05	0.000143	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CREB1—hematologic cancer	1.05e-05	0.000142	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	1.04e-05	0.000141	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.04e-05	0.000141	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—BRAF—hematologic cancer	1.03e-05	0.00014	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMMR—hematologic cancer	1.03e-05	0.00014	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—IDH2—hematologic cancer	1.03e-05	0.00014	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL2—hematologic cancer	1.02e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6R—hematologic cancer	1.02e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	1.02e-05	0.000139	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SDC1—hematologic cancer	1.01e-05	0.000138	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	1.01e-05	0.000138	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JAK2—hematologic cancer	1.01e-05	0.000138	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	1e-05	0.000136	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	9.91e-06	0.000135	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MDM2—hematologic cancer	9.87e-06	0.000134	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ESR1—hematologic cancer	9.83e-06	0.000134	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	9.73e-06	0.000132	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FN1—hematologic cancer	9.71e-06	0.000132	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.68e-06	0.000132	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	9.66e-06	0.000131	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MTOR—hematologic cancer	9.6e-06	0.000131	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	9.6e-06	0.000131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	9.59e-06	0.00013	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—BAD—hematologic cancer	9.59e-06	0.00013	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	9.57e-06	0.00013	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	9.5e-06	0.000129	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	9.46e-06	0.000129	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CA9—hematologic cancer	9.42e-06	0.000128	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ACP5—hematologic cancer	9.42e-06	0.000128	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CD80—hematologic cancer	9.31e-06	0.000127	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOR2—hematologic cancer	9.29e-06	0.000126	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	9.29e-06	0.000126	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KIT—hematologic cancer	9.29e-06	0.000126	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	9.29e-06	0.000126	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FGF2—hematologic cancer	9.25e-06	0.000126	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	9.17e-06	0.000125	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	9.13e-06	0.000124	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	9.12e-06	0.000124	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	9.01e-06	0.000123	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	8.92e-06	0.000121	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	8.9e-06	0.000121	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JAK2—hematologic cancer	8.87e-06	0.000121	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—IDH1—hematologic cancer	8.85e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CREB1—hematologic cancer	8.84e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—hematologic cancer	8.83e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2—hematologic cancer	8.82e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—hematologic cancer	8.78e-06	0.000119	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.75e-06	0.000119	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.75e-06	0.000119	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TXN—hematologic cancer	8.75e-06	0.000119	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—BRAF—hematologic cancer	8.73e-06	0.000119	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	8.69e-06	0.000118	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MDM2—hematologic cancer	8.66e-06	0.000118	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL2—hematologic cancer	8.65e-06	0.000118	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CD44—hematologic cancer	8.63e-06	0.000117	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NQO1—hematologic cancer	8.63e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6R—hematologic cancer	8.63e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	8.61e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCND1—hematologic cancer	8.6e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JUN—hematologic cancer	8.58e-06	0.000117	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.57e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MTOR—hematologic cancer	8.42e-06	0.000115	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	8.42e-06	0.000115	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	8.32e-06	0.000113	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTEN—hematologic cancer	8.3e-06	0.000113	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	8.23e-06	0.000112	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	8.22e-06	0.000112	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	8.17e-06	0.000111	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYCS—hematologic cancer	8.16e-06	0.000111	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	8.12e-06	0.00011	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	8.11e-06	0.00011	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	8.1e-06	0.00011	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	8.09e-06	0.00011	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	8.04e-06	0.000109	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	8.01e-06	0.000109	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CRABP1—hematologic cancer	8.01e-06	0.000109	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	7.99e-06	0.000109	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EP300—hematologic cancer	7.91e-06	0.000108	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	7.9e-06	0.000107	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGF2—hematologic cancer	7.82e-06	0.000106	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	7.82e-06	0.000106	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.8e-06	0.000106	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—hematologic cancer	7.75e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2—hematologic cancer	7.73e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	7.71e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SRC—hematologic cancer	7.7e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—hematologic cancer	7.7e-06	0.000105	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NUP98—hematologic cancer	7.56e-06	0.000103	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCND1—hematologic cancer	7.54e-06	0.000103	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JUN—hematologic cancer	7.52e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	7.5e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JAK2—hematologic cancer	7.49e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—hematologic cancer	7.42e-06	0.000101	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NRAS—hematologic cancer	7.4e-06	0.000101	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	7.34e-06	9.99e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.34e-06	9.98e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.34e-06	9.98e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MDM2—hematologic cancer	7.32e-06	9.95e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	7.29e-06	9.92e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NUP214—hematologic cancer	7.28e-06	9.91e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTEN—hematologic cancer	7.28e-06	9.9e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTP1—hematologic cancer	7.2e-06	9.79e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTR—hematologic cancer	7.14e-06	9.71e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.14e-06	9.71e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	7.12e-06	9.68e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MTOR—hematologic cancer	7.12e-06	9.68e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	7.12e-06	9.68e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	7.1e-06	9.65e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	7.09e-06	9.64e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENO2—hematologic cancer	7e-06	9.52e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EP300—hematologic cancer	6.94e-06	9.44e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—hematologic cancer	6.9e-06	9.38e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	6.88e-06	9.36e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.81e-06	9.26e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	6.8e-06	9.24e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.79e-06	9.23e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SRC—hematologic cancer	6.75e-06	9.18e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	6.68e-06	9.08e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SDC1—hematologic cancer	6.63e-06	9.02e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NCOR1—hematologic cancer	6.61e-06	8.99e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTM1—hematologic cancer	6.61e-06	8.99e-05	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	6.61e-06	8.99e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	6.57e-06	8.94e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—hematologic cancer	6.55e-06	8.9e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2—hematologic cancer	6.54e-06	8.89e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—hematologic cancer	6.51e-06	8.85e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—hematologic cancer	6.5e-06	8.84e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NRAS—hematologic cancer	6.49e-06	8.83e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KRAS—hematologic cancer	6.37e-06	8.67e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCND1—hematologic cancer	6.37e-06	8.67e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JUN—hematologic cancer	6.36e-06	8.65e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	6.22e-06	8.46e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	6.16e-06	8.38e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTEN—hematologic cancer	6.15e-06	8.36e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—hematologic cancer	6.05e-06	8.22e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	6.03e-06	8.2e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	6.02e-06	8.18e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	6e-06	8.16e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EP300—hematologic cancer	5.87e-06	7.98e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	5.85e-06	7.96e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.84e-06	7.95e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SRC—hematologic cancer	5.7e-06	7.76e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—hematologic cancer	5.66e-06	7.7e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CD44—hematologic cancer	5.64e-06	7.67e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NQO1—hematologic cancer	5.64e-06	7.67e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KRAS—hematologic cancer	5.59e-06	7.6e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	5.56e-06	7.55e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—hematologic cancer	5.5e-06	7.48e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NRAS—hematologic cancer	5.49e-06	7.46e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HRAS—hematologic cancer	5.42e-06	7.37e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYCS—hematologic cancer	5.34e-06	7.26e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.3e-06	7.21e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	5.26e-06	7.15e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—hematologic cancer	5.18e-06	7.05e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	5.13e-06	6.98e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—hematologic cancer	5.11e-06	6.95e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	5.1e-06	6.93e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—hematologic cancer	4.97e-06	6.75e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.91e-06	6.68e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—hematologic cancer	4.78e-06	6.5e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HRAS—hematologic cancer	4.75e-06	6.46e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KRAS—hematologic cancer	4.72e-06	6.42e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.71e-06	6.4e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.55e-06	6.19e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—hematologic cancer	4.55e-06	6.18e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.45e-06	6.06e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	4.34e-06	5.9e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.32e-06	5.88e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.32e-06	5.88e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.32e-06	5.87e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—hematologic cancer	4.26e-06	5.8e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—hematologic cancer	4.2e-06	5.71e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—hematologic cancer	4.19e-06	5.7e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.08e-06	5.54e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HRAS—hematologic cancer	4.01e-06	5.46e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—hematologic cancer	3.84e-06	5.22e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.82e-06	5.2e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.76e-06	5.12e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—hematologic cancer	3.54e-06	4.82e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTEN—hematologic cancer	3.25e-06	4.42e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.21e-06	4.37e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—EP300—hematologic cancer	3.1e-06	4.22e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.98e-06	4.05e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.82e-06	3.84e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—hematologic cancer	2.79e-06	3.79e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.67e-06	3.62e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.46e-06	3.35e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.29e-06	3.12e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTEN—hematologic cancer	2.13e-06	2.89e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—EP300—hematologic cancer	2.03e-06	2.76e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—hematologic cancer	1.87e-06	2.55e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.5e-06	2.04e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.23e-06	1.67e-05	CbGpPWpGaD
